Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Sun Pharma Advanced Research Company

BSE: 532872|NSE: SPARC|ISIN: INE232I01014|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 26, 16:00
286.35
4.2 (1.49%)
VOLUME 52,924
LIVE
NSE
May 26, 15:59
287.20
5.5 (1.95%)
VOLUME 181,437
Announcements on Sun Pharma Adv

19th-May-2017 19:02Source: BSE

Sun Pharma Adv- Updates

This is to inform you that, the Company has received a Complete Response Letter (CRL) from the USFDA for its New Drug Application (NDA) for Elepsia XRTM, Levetiracetam extended-release tablets 1000 mg...

11th-May-2017 17:39Source: BSE

Sun Pharma Adv- Updates

We refer to our letter no. SPARC/Sec/SE/2017-18/008 dated 5th May 2017 intimating the outcome of Board Meeting held on the same date and submitting, inter alia, the Audited Financial Results for the...

10th-May-2017 12:10Source: BSE

Sun Pharma Adv- Fixes Book Closure for EGM

Sun Pharma Advanced Research Company Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from May 27, 2017 to June 02, 2017 (both days inclusive)...

9th-May-2017 13:26Source: NSE

Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research Company Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from May 27, 2017 to June 2, 2017 for th...

9th-May-2017 11:32Source: NSE

Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on Jun 02, 2017

9th-May-2017 11:12Source: BSE

Sun Pharma Adv- EGM on June 02, 2017

Sun Pharma Advanced Research Company Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company will be held on June 02, 2017.

9th-May-2017 11:07Source: BSE

Sun Pharma Adv- Notice Of EGM On 2Nd June 2017

Pursuant to clause 12 of Part A of Schedule III read with regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015 we are pleased to enclose herewith the Notice of Ext...

6th-May-2017 16:32Source: BSE

Sun Pharma Adv- Statement Of Deviations Or Variations Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Sun Pharma Advanced Research Company Limited had issued and allotted 10204081 fully paid up equity shares of face value of Re. 1 each for cash at a price of Rs. 245 per equity shares (including share ...

5th-May-2017 14:53Source: NSE

Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding Outcome of Board Meeting held on May 05, 2017.

5th-May-2017 14:52Source: NSE

Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research Company Limited has submitted to the Exchange, the financial results for the period ended March 31, 2017.

1 2 3 4 5 Next >>
Quick Links for Sun Pharma Advanced Research Company
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.